118 algorithm-development-"Prof"-"Prof" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
NHS Foundation Trust. The post holder will be a member of the Retinal Disease and Repair Group (Xue Lab) with responsibility for carrying out research to develop advanced therapies for inherited
-
to develop advanced therapies for inherited diseases of the eye as part of the new MRC Centre of Research Excellence (CoRE) in Therapeutic Genomics. The post holder will provide guidance to less experienced
-
scientists, forming small teams focused on ambitious, ‘blue sky’ research for novel methods development relevant for drug discovery analysis pipelines, trial design and operational efficiency. Led by Professor
-
are passionate about applying machine learning to real-world clinical challenges. The successful candidate will lead the development and validation of predictive models using multimodal data including neuroimaging
-
-year, renewable, high-profile research initiative funded by the European Commission, bringing together leading research teams from across the Eurozone to develop state-of-the-art multimodal LLMs. This is
-
. The role spans two cutting-edge research projects developing digital tools for faster, smarter battery testing and advanced management systems to enhance battery performance in heavy industry. You’ll develop
-
researchers will extend and apply the ideas of active matter physics in biological contexts, developing theories and cell-scale and continuum computational models. The work will focus on identifying physical
-
We are seeking to appoint a Senior Postdoctoral Researcher in Statistical Machine Learning and Deep Generative Modelling to apply and develop cutting-edge deep generative probabilistic models
-
lab has developed the OrthoFinder comparative genomic methods. OrthoFinder has become widely-used in comparative genomics research, it powers many popular databases of online genomic information, and
-
world-leading researchers from Oxford, Harvard, and other premier institutions to develop innovative gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases